Live Analyst Rating Changes 26825 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Michael Piccolo
WEDB

Michael Piccolo

Wedbush
Wall Street Analyst
★★☆☆☆
#2793
on 13Foresight · ranked by our own returns
45%
Success Rate
+1.2%
Average Return
15 of 33 calls profitable · +10.3% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 45% of Michael Piccolo's ratings turned a profit when each position was held for 1 year — averaging +1.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

30 Buy 9 Hold 0 Sell
Michael's Stock Coverage 18 ratings · 2026-08-22
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
WLDN
Willdan Group
 Aug 18, 2026 BUY Strong Buy
+12.9% avg upside
8 analysts
$130.00
51.95% Upside
 +1.2% ·
SOLV
Solventum Corporation
 Aug 06, 2026 BUY Buy
+2.3% avg upside
16 analysts
$101.00
12.84% Upside
 +8.0% ·
TASK
TaskUs
 Aug 06, 2026 BUY Buy
+120.8% avg upside
15 analysts
$9.00
12.50% Upside
 +3.3% ·
NXH
Neighborhood Intelligence
 Aug 05, 2026 BUY Hold
+251.2% avg upside
21 analysts
$10.00
141.02% Upside
 -7.8% ·
FMCC
Freddie Mac
 Jul 31, 2026 BUY Buy
+91.1% avg upside
9 analysts
$12.00
110.06% Upside
 +5.1% ·
TRIP
TripAdvisor
 Jul 30, 2026 BUY Hold
+153.2% avg upside
42 analysts
$20.00
100.06% Upside
 -24.3% ·
FNMA
Federal National Mortgage Association
 Jul 30, 2026 BUY Buy
+74.7% avg upside
9 analysts
$8.00
27.26% Upside
 +4.8% ·
RITM
Rithm Capital
 Jul 29, 2026 BUY Strong Buy
+26.5% avg upside
16 analysts
$12.50
22.73% Upside
 +2.0% ·
RPT
Rithm Property Trust
 Jul 29, 2026 BUY Buy
+44.8% avg upside
19 analysts
$24.00
81.74% Upside
 +7.4% ·
STAA
Staar Surgical
 Jul 20, 2026 BUY Hold
+44.9% avg upside
16 analysts
$40.00
72.88% Upside
 -3.5% ·
BUR
Burford Capital
 May 11, 2026 HOLD Strong Buy
+195.9% avg upside
8 analysts
$5.00
15.95% Upside
 -7.0% ·
QBTS
D-Wave Quantum
 May 07, 2026 BUY Strong Buy
+71.2% avg upside
22 analysts
$40.00
96.10% Upside
 -2.5% ·
HIMS
Hims & Hers Health
 Aug 09, 2024 HOLD Buy
-17.1% avg upside
22 analysts
$17.00
49.58% Downside
 +225.4% ·
NSSC
Napco Security Technologies
 May 06, 2024 BUY Strong Buy
+26.5% avg upside
8 analysts
$51.00
33.81% Upside
 -44.7% ·
SKIN
Beauty Health
 Sep 19, 2023 BUY Hold
+391.9% avg upside
11 analysts
$14.00
2042.87% Upside
 -74.7% ·
GETY
Getty Images Holdings
 Aug 15, 2023 BUY Buy
+4115.1% avg upside
8 analysts
$5.75
2080.48% Upside
 -21.6% ·
SSTI
SoundThinking Inc
 Aug 10, 2023 BUY Strong Buy
+224.4% avg upside
15 analysts
$25.00
305.28% Upside
 -22.5% ·
HLLY
Holley
 Aug 09, 2022 BUY Strong Buy
+134.5% avg upside
13 analysts
$10.00
223.59% Upside
 +0.3% ·
🔒 13 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Michael Piccolo — Frequently Asked Questions
How accurate are Michael Piccolo's stock ratings?
Based on the calls 13Foresight could measure, about 45% of Michael's ratings were profitable over a one-year hold, with an average return of +1.2% per rating, or +10.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Michael ranked on 13Foresight?
Michael Piccolo is currently ranked #2793 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Michael cover?
Michael most recently has ratings on WLDN, SOLV, TASK, NXH, FMCC, TRIP, FNMA, RITM, RPT, STAA, BUR, QBTS and 6 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.